Literature DB >> 8200351

Copper-atom identification in the active and inactive forms of plasma-derived FVIII and recombinant FVIII-delta II.

N Bihoreau1, S Pin, A M de Kersabiec, F Vidot, M P Fontaine-Aupart.   

Abstract

The plasma-derived factor VIII (pd-FVIII) circulates as different heterodimers of heavy and light chains associated by a metallic ion still present in the functional activated factor VIII trimer of molecular mass 50,000-45,000-70,000 Da. The chelation of the metal leads to the dissociation of these complexes with a concomitant loss of the procoagulant activity. Until now, this ion has not been directly identified and its role in the structure/function relationships remains unclear. We report the first determination of the nature of this metal using atomic-absorption spectroscopy with Zeeman effect. A comparative identification was also performed with the new recombinant factor VIII, FVIII-delta II. In the different active pd-FVIII heterodimers (of molecular mass ranging over 210,000-80,000-90,000-80,000 Da) and in FVIII-delta II, copper was detected. This result is consistent with sequence similarities described between FVIII and copper-binding proteins. The quantification of the copper content in FVIII-delta II and in the corresponding pd-FVIII dimer of 90,000-80,000 Da indicated, for both proteins, the presence of one copper ion/mol FVIII. Copper was also identified in the activated FVIII complex and remained in the dimer of 50,000-70,000 Da generated during FVIII inactivation. Further dissociation into isolated fragments of molecular masses 70,000 Da and 50,000 Da was concomitant with the loss of the copper ion. No copper was detected in the isolated fragment of molecular mass 45,000 Da. These results suggest that the presence of the cation is not directly related to FVIII activity but is an essential structural prerequisite for FVIII heavy-light-chain association.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200351     DOI: 10.1111/j.1432-1033.1994.tb18839.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Correlation of rFVIII inactivation with aggregation in solution.

Authors:  Wei Wang; Drew N Kelner
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

2.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

3.  pH-dependent association of factor VIII chains: enhancement of affinity at physiological pH by Cu2+.

Authors:  Hironao Wakabayashi; Qian Zhou; Keiji Nogami; Charles Ansong; Fatbardha Varfaj; Stephen Miles; Philip J Fay
Journal:  Biochim Biophys Acta       Date:  2006-04-22

Review 4.  Combined factors V and VIII deficiency climbs onto the map.

Authors:  J E Sadler
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  Structural comparison of cupredoxin domains: domain recycling to construct proteins with novel functions.

Authors:  M E Murphy; P F Lindley; E T Adman
Journal:  Protein Sci       Date:  1997-04       Impact factor: 6.725

6.  Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association.

Authors:  Abed R Zeibdawi; Jean E Grundy; Bogna Lasia; Edward L G Pryzdial
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 7.  Factor VIII structure and function.

Authors:  Philip J Fay
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

8.  Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.

Authors:  B O Villoutreix; B Dahlbäck
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.